Table 1.
Overview of data assessing the prevalence of prediabetes and DM type 2 in stroke/TIA/ICH patients during the acute stroke phase (<3 months after vascular event)
| Population | Vascular event | Glucose measurement | Number of patients | Normoglycemic, n (%) | Prediabetes, n (%) | DM type 2, n (%) |
|---|---|---|---|---|---|---|
| Europe | IS | OGTT | 96 | 15 (16) | 37 (39) | 44 (46) |
| Europe | IS, TIA, ICH | FPG, OGTT | 190 | 94 (49) | 57 (30) | 39 (21) |
| Japan | IS | FPG, OGTT | 113 | 42 (37) | 43 (38) | 28 (25) |
| South Africa | IS | FPG, OGTT | 107 | 42 (39) | 39 (36) | 26 (24) |
| China | IS | FPG, OGTT | 1,793 | 706 (39) | 556 (31) | 531 (30) |
| US | IS | HbA1c | 166 | 53 (32) | 88 (53) | 25 (15) |
| Europe | IS, TIA, ICH | FPG, OGTT, HbA1c | 700 | 147 (21) | 365 (52) | 188 (27) |
| Total | 3,165 | 1,099 (35) | 1,185 (37) | 881 (28) |
Note: Reproduced from Fonville S, Zandbergen AA, Koudstaal PJ, den Hertog HM. Prediabetes in patients with stroke or transient ischemic attack: prevalence, risk and clinical management. Cerebrovasc Dis. 2014;37(6):393–400. Copyright © 2014 Karger Publishers, Basel, Switzerland.6
Abbreviations: DM, diabetes mellitus; TIA, transient ischemic attack; ICH, intracerebral hemorrhage; IS, ischemic stroke; OGTT, oral glucose tolerance test; FPG, fasting plasma glucose; HbA1c, glycosylated hemoglobin.